rs5974620
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_004840.3(ARHGEF6):c.891G>T(p.Gln297His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00156 in 1,205,188 control chromosomes in the GnomAD database, including 19 homozygotes. There are 498 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0080 ( 8 hom., 239 hem., cov: 23)
Exomes 𝑓: 0.00090 ( 11 hom. 259 hem. )
Consequence
ARHGEF6
NM_004840.3 missense
NM_004840.3 missense
Scores
4
9
Clinical Significance
Conservation
PhyloP100: 1.17
Genes affected
ARHGEF6 (HGNC:685): (Rac/Cdc42 guanine nucleotide exchange factor 6) Rho GTPases play a fundamental role in numerous cellular processes that are initiated by extracellular stimuli that work through G protein coupled receptors. The encoded protein belongs to a family of cytoplasmic proteins that activate the Ras-like family of Rho proteins by exchanging bound GDP for GTP. It may form a complex with G proteins and stimulate Rho-dependent signals. This protein is activated by PI3-kinase. Mutations in this gene can cause X-chromosomal non-specific cognitive disability. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
?
Computational evidence support a benign effect (MetaRNN=0.019119442).
BP6
?
Variant X-136708707-C-A is Benign according to our data. Variant chrX-136708707-C-A is described in ClinVar as [Likely_benign]. Clinvar id is 446067.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-136708707-C-A is described in Lovd as [Benign]. Variant chrX-136708707-C-A is described in Lovd as [Likely_benign].
BS1
?
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00802 (897/111855) while in subpopulation AFR AF= 0.0275 (848/30801). AF 95% confidence interval is 0.026. There are 8 homozygotes in gnomad4. There are 239 alleles in male gnomad4 subpopulation. This position pass quality control queck.
BS2
?
High Homozygotes in GnomAd at 8 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ARHGEF6 | NM_004840.3 | c.891G>T | p.Gln297His | missense_variant | 8/22 | ENST00000250617.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ARHGEF6 | ENST00000250617.7 | c.891G>T | p.Gln297His | missense_variant | 8/22 | 1 | NM_004840.3 | P1 | |
ARHGEF6 | ENST00000370622.5 | c.429G>T | p.Gln143His | missense_variant | 7/21 | 1 | |||
ARHGEF6 | ENST00000370620.5 | c.429G>T | p.Gln143His | missense_variant | 7/21 | 2 |
Frequencies
GnomAD3 genomes ? AF: 0.00803 AC: 898AN: 111803Hom.: 8 Cov.: 23 AF XY: 0.00703 AC XY: 239AN XY: 34013
GnomAD3 genomes
?
AF:
AC:
898
AN:
111803
Hom.:
Cov.:
23
AF XY:
AC XY:
239
AN XY:
34013
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00237 AC: 434AN: 183285Hom.: 3 AF XY: 0.00152 AC XY: 103AN XY: 67761
GnomAD3 exomes
AF:
AC:
434
AN:
183285
Hom.:
AF XY:
AC XY:
103
AN XY:
67761
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000895 AC: 979AN: 1093333Hom.: 11 Cov.: 29 AF XY: 0.000721 AC XY: 259AN XY: 359219
GnomAD4 exome
AF:
AC:
979
AN:
1093333
Hom.:
Cov.:
29
AF XY:
AC XY:
259
AN XY:
359219
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.00802 AC: 897AN: 111855Hom.: 8 Cov.: 23 AF XY: 0.00701 AC XY: 239AN XY: 34075
GnomAD4 genome
?
AF:
AC:
897
AN:
111855
Hom.:
Cov.:
23
AF XY:
AC XY:
239
AN XY:
34075
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
108
ESP6500EA
AF:
AC:
1
ExAC
?
AF:
AC:
328
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Apr 19, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | Invitae | Dec 31, 2019 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 12, 2015 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
Cadd
Benign
Dann
Uncertain
FATHMM_MKL
Uncertain
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationTaster
Benign
P;P;P;P
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;D
REVEL
Benign
Sift
Benign
T;T;T
Sift4G
Benign
T;T;T
Polyphen
0.88
.;.;P
Vest4
MutPred
0.17
.;.;Gain of catalytic residue at L299 (P = 0.0589);
MVP
MPC
0.28
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at